^
Association details:
Biomarker:BST1 positive
Cancer:Acute Myelogenous Leukemia
Drug:S63845 (MCL1 inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: D – Preclinical
Source:
Title:

CD157/BST-1 mediates pro-survival signals in acute myeloid leukemia

Published date:
05/28/2021
Excerpt:
...S63845 significantly increases the therapeutic efficacy of AraC in CD157-positive but not in CD157-negative AML..